D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
ENGNW holding history
enGene Therapeutics Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ENGNW overviewAll 13F holders of ENGNWFull Q2 2026 holdings
- Shares (Q2 2026)
- 104,622
- Value
- $30.3K
- % of portfolio
- <0.1%
- Quarters held
- 11
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 104,622 | $30.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 104,622 | $275.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 104,622 | $313.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 104,622 | $75.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 104,622 | $70.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 104,622 | $67.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 104,622 | $88.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 104,622 | $209.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 104,622 | $145.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 104,622 | $544.0K | <0.1% | −100−0.1% | Reduced | Holders |
| Q4 2023 | 104,722 | $89.0K | <0.1% | +104,722 | New | Holders |